A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

In this article we are going to use hedge fund sentiment as a tool and determine whether Intevac, Inc. (NASDAQ:IVAC) is a good investment right now. We like to analyze hedge fund sentiment before ...

180 Degree Capital Corp., an investment management firm, recently released its second quarter 2023 investor letter. A copy of the same can be downloaded here. The quarter was rough for the portfolio, ...

New research reports the creation of a degradation-based cancer vaccine that penetrates tumor cells and converts them into ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

One stock that might be an intriguing choice for investors right now is Intevac, Inc.IVAC. This is because this security in the Electronics - Manufacturing Machinery space is seeing solid earnings ...

Intevac's (NASDAQ:IVAC) stock is up by a considerable 18% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term ...

SANTA CLARA, Calif., November 11, 2024--Intevac, Inc. (Nasdaq: IVAC), a leading supplier of thin-film processing systems, today announced the appointment of Ryan L. Vardeman to its board of directors ...

Burkitt lymphoma (BL) is a highly aggressive form of non-Hodgkin lymphoma (NHL) that comes in three different variants: endemic, immunodeficiency-associated, and sporadic. Of these variants, sporadic ...